Pfizer Inc. CEO Albert Bourla discusses how uncertainty over proposed pharmaceutical tariffs by President Trump is limiting the company's investment in the US, despite reporting an...
Pfizer CEO Albert Bourla highlights how uncertainty over proposed pharmaceutical tariffs by President Trump is limiting the company's investment in the US, despite reporting an 8% ...
The Swiss Market Index plummeted over 5% as US President Trump's announcement of major tariffs on pharmaceuticals led to a selloff in Swiss pharma stocks, with Novartis and Roche a...
The Swiss Market Index fell over 5% as US tariffs on pharmaceuticals sparked a selloff in Swiss pharma stocks, with Novartis and Roche shares dropping significantly.
The Swiss Market Index plunged over 5% as US President Donald Trump's announcement of major tariffs on pharmaceuticals caused a selloff in Swiss pharma stocks, with Novartis and Ro...
The Swiss Market Index dropped over 5% as US tariff threats on pharmaceuticals caused a selloff, significantly affecting Swiss pharma companies like Novartis and Roche.
The US stock market faced a downturn as President Trump's new tariffs on Chinese imports and upcoming pharmaceutical tariffs sparked investor concerns, with mixed performances acro...
The US has escalated trade tensions by imposing a 104% tariff on Chinese imports, while prioritizing alliances with Japan and South Korea. Trump's administration signals further ta...
President Trump has set a 25% tariff on South Korea and plans new tariffs on semiconductors and pharmaceuticals, causing stock market volatility and international trade discussions...
